Initially characterized in 1976 [46], P-glycoprotein (PGP) is an essential mediator of drug metabolism and poses a challenge in treating cancers by causing multidrug resistance in tumors, which gives PGP its alternative name Multidrug Resistance Protein 1 (MDR1). Here, ABCB1 is linked to cancer.